Long-Term Pill Use, High Parity Raise Cervical Cancer Risk among Women with Human Papillomavirus Infection
Klitsch, M.
International Family Planning Perspectives 28(3): 176-177
2002
ISSN/ISBN: 0190-3187 DOI: 10.2307/3088262Document Number: 254370
Document emailed within 0-6 h
Related Documents
Langley, C.L.; Benga-De, E.; Critchlow, C.W.; Ndoye, I.; Mbengue-Ly, M.D.; Kuypers, J.; Woto-Gaye, G.; Mboup, S.; Bergeron, C.; Holmes, K.K.; Kiviat, N.B. 1996: HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women Aids 10(4): 413-417Li, C.; Ma, C.; Zhang, W.; Wang, J. 2014: The immune function differences and high-risk human papillomavirus infection in the progress of cervical cancer European Journal of Gynaecological Oncology 35(5): 557-561
Ting, J.; Mugo, N.; Kwatampora, J.; Hill, C.; Chitwa, M.; Patel, S.; Gakure, H.; Kimani, J.; Schoenbach, V.J.; Poole, C.; Smith, J.S. 2013: High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya Sexually Transmitted Diseases 40(7): 584-589
Veldhuijzen, N.J.; Vyankandondera, J.; van de Wijgert, J.H. 2010: HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda Aids 24(14): 2289-2292
Dames, D.N.; Blackman, E.; Butler, R.; Taioli, E.; Eckstein, S.; Devarajan, K.; Griffith-Bowe, A.; Gomez, P.; Ragin, C. 2014: High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas Plos one 9(1): E85429
Sirimai, K.; Chalermchockcharoenkit, A.; Roongpisuthipong, A.; Pongprasobchai, S. 2004: Associated risk factors of human papillomavirus cervical infection among human immunodificiency virus-seropositive women at Siriraj Hospital Journal of the Medical Association of Thailand 87(3): 270-276
Musa, J.; Taiwo, B.; Achenbach, C.; Olugbenga, S.; Berzins, B.; Sagay, A.S.; Idoko, J.A.; Kanki, P.J.; Murphy, R.L. 2013: High-risk human papillomavirus among HIV-infected women with normal cervical cytology: a pilot study in Jos, Nigeria Archives of Gynecology and Obstetrics 288(6): 1365-1370
Obeidat, B.; Matalka, I.; Mohtaseb, A.; Jaradat, S.; Hayajneh, W.; Khasawneh, R.; Haddad, H.; Obeidat, F. 2013: Prevalence and distribution of high-risk human papillomavirus genotypes in cervical carcinoma, low-grade, and high-grade squamous intraepithelial lesions in Jordanian women European Journal of Gynaecological Oncology 34(3): 257-260
Rahman, M.; Sasagawa, T.; Yamada, R.; Kingoro, A.; Ichimura, H.; Makinoda, S. 2011: High prevalence of intermediate-risk human papillomavirus infection in uterine cervices of Kenyan women infected with human immunodeficiency virus Journal of Medical Virology 83(11): 1988-1996
Castilho, J.L.; Levi, Jé.Eduardo.; Luz, P.M.; Cambou, M.Catherine.; Vanni, T.; de Andrade, A.; Derrico, Mônica.; Veloso, Véa.G.; Grinsztejn, B.; Friedman, R.K. 2015: A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil Bmc Cancer 15: 478
Farzaneh, F.; Shirvani, H.Esmaeilnia.; Barouti, E.; Salehpour, S.; Khodakarami, N.; Alizadeh, K. 2011: Knowledge and attitude of women regarding the human papillomavirus (HPV) infection, its relationship to cervical cancer and prevention methods Medical Journal of Malaysia 66(5): 468-473
Marais, D.; Gawarecki, D.; Allan, B.; Ahmed, K.; Altini, L.; Cassim, N.; Gopolang, F.; Hoffman, M.; Ramjee, G.; Williamson, A.-L. 2011: The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection Antiviral Therapy 16(8): 1219-1226
Veldhuijzen, N.J.; Braunstein, S.L.; Vyankandondera, J.; Ingabire, C.; Ntirushwa, J.; Kestelyn, E.; Tuijn, C.; Wit, F.W.; Umutoni, A.; Uwineza, M.; Crucitti, T.; van de Wijgert, J.H.H.M. 2011: The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda Bmc Infectious Diseases 11: 333
Liu, X.; Feng, A.; Cui, Y.; Tobe, R.Gai. 2013: Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women? Bioscience Trends 7(4): 159-167
Liebrich, C.; Brummer, O.; Von Wasielewski, R.; Wegener, G.; Meijer, C.; Iftner, T.; Petry, K.U. 2009: Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents European Journal of Gynaecological Oncology 30(1): 45-48
Asiimwe, S.; Whalen, C.C.; Tisch, D.J.; Tumwesigye, E.; Sethi, A.K. 2008: Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda International Journal of Std and Aids 19(9): 605-610
Vamos, C.A.; Calvo, A.E.; Daley, E.M.; Giuliano, A.R.; López Castillo, H. 2015: Knowledge, Behavioral, and Sociocultural Factors Related to Human Papillomavirus Infection and Cervical Cancer Screening Among Inner-City Women in Panama Journal of Community Health 40(6): 1047-1056
Yamada, R.; Sasagawa, T.; Kirumbi, L.W.; Kingoro, A.; Karanja, D.K.; Kiptoo, M.; Nakitare, G.W.; Ichimura, H.; Inoue, M. 2008: Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection Journal of Medical Virology 80(5): 847-855
Fanta, B.E. 2005: The distribution of Human Papilloma Virus infection in women with cervical histological abnormalities from an area with high incidence of cervical cancer Ethiopian Medical Journal 43(3): 151-158
Boonyanurak, P.; Panichakul, S.; Wilawan, K. 2010: Prevalence of high-risk human papillomavirus infection (HPV) and correlation with postmenopausal hormonal therapy in Thai women aged more than 45 years old Journal of the Medical Association of Thailand 93(1): 9-16